The manufacturing process for human hepatitis B
immunoglobulin contains a step of low pH incubation for viral inactivation. It
contains a suitable amount of glycine as stabilizer, but does not contain any
antiseptic or antibiotic.
Indications:
-Post-exposure prophylaxis should be considered
following percutaneous or permucosal exposure to HBsAg-positive or suspected
HBsAg-positive material, for example, by needle, oral ingestion or sexual
exposure.
-For prophylaxis in infants born to HBsAg-positive
mothers. Mainly designated for prophylaxis of hepatitis B and suitable for
use in Liver transplantation
Strength: 400IU/vial (4ml) ,200IU/vial (2ml),100 IU/vial(1ml) -Post-exposure prophylaxis in persons who did not receive prior vaccinations, or whose prior vaccination regimen is incomplete, or when hepatitis B antibody levels are inadequate (<10 IU/L).
CN